PRMT5P1

Across TCGA pan-cancer cohorts, PRMT5P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PRMT5P1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where PRMT5P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PRMT5P1 is over-expressed in tumor.

COAD and KICH are the cancer types where PRMT5P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PRMT5P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.098	.003	6	view →
KICH	Male	All	+0.027	.029	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

PRMT5P1–COAD

Open the COAD breakdown →